Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro | Zendy

U.M. Morgan | Zendy; J.A. Reynoldson | Zendy; R.C.A. Thompson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro

Author(s) -

U.M. Morgan,

J.A. Reynoldson,

R.C.A. Thompson

Publication year - 1993

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.37.2.328

Subject(s) - oxfendazole , mebendazole , albendazole , fenbendazole , giardia , in vivo , biology , in vitro , pharmacology , nocodazole , microbiology and biotechnology , anthelmintic , biochemistry , zoology , cytoskeleton , cell

Previous studies in our laboratory have shown that albendazole is effective against Giardia spp. in vitro and in vivo, prompting an investigation of the effects of several related benzimidazoles (BZs) on the viability of this protozoan parasite. A range of BZs was tested, and their effects were compared with those of a number of microtubule inhibitors. The effects produced by the two types of drugs were markedly similar, namely, trophozoite detachment and distortion of morphology and general structure, indicating a potential antimicrotubule mode of action for BZs. Mebendazole, albendazole, and fenbendazole proved to be among the most effective BZs tested, exhibiting apparent irreversibility. Nocodazole, oxfendazole, and albendazole sulfoxide, among others, produced transient inhibitions only. Further studies are required to evaluate all available BZs and other antigiardial agents to ensure the development of the most effective and safest antigiardial agent possible.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research